CAH Stock Analysis: Buy, Sell, or Hold?
CAH - Cardinal Health, Inc.
$229.51
1.05 (0.46%)
â˛
5d:
-2.41%
30d:
+1.56%
90d:
+14.41%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 19, 2026 at $233.23 · last confirmed Aug 20, 2026
Strength: 4.6/10
Get Alerted When CAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CAH is fairly priced but lacks strong directional signals. At 0.3% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CAH is fairly priced but lacks strong directional signals. At 0.3% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$380.34
Based on 10.9% avg growth
INTRINSIC VALUE TODAY
$236.16
2.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CAH is currently trading at $229.51, which is considered fair relative to its 30-day fair value range of $226.89 to $236.13. The stock's valuation (Forward PE: 19.0) is in line with its historical norms (18.9). At these levels, the market is pricing in 0.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CAH is in a strong uptrend. The price is currently testing key support at $228.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CAH scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $270.94 (+18.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CAH is in a strong uptrend. The price is currently testing key support at $228.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CAH scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $270.94 (+18.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$226.89 -
$236.13
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
Protect Your Profits
Holding CAH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (34/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($270.94)
- NEUTRAL: Market pricing in 0.3% annual earnings growth - fairly valued
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$226.89 -
$236.13
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$228.16
Resistance Level
$258.30
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.04
Wall Street Target
$270.94
(+18.1%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
68.8%
Profit Margin
0.7%
Valuation Premium vs History
+0.3% premium
PE vs Historical
19.0 vs 18.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.3%
(market-implied from PE analysis)
1-Year Target
$230.20
(+0%)
2-Year Target
$230.89
(+1%)
3-Year Target
$231.58
(+1%)
3-Yr Target (if PE normalizes)
(PE: 19â19)
PE COMPRESSION
$229.89
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 17.8%)
$395.86
(+73%)
Base:
(SPY PE: 19.0, Growth: 17.8%)
$375.53
(+64%)
Bear:
(PE: 16.2, Growth: 17.8%)
$319.20
(+39%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 32.45 | Current EPS (TTM): $7.04
Bull Case
$430.32
(+88%)
Analyst growth 71.2%, PE expands to 35.7
Base Case
$391.20
(+70%)
Market implied 71.2%, PE stable at 32.5
Bear Case
$155.35
(-32%)
Severe decline -20.0%, PE contracts to 27.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 1:27 AM ET
Data refreshes hourly during market hours. Next update: 2:27 AM
Data refreshes hourly during market hours. Next update: 2:27 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$991 | 52 HOLD |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$373 | 52 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$98 | 40 SELL |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 52 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 46 HOLD |
Advanced CAH Option Strategies
Professional options setups generated by AI based on today's CAH price and gamma walls.
